Hindrances in management of diabetic retinopathy

Journal Title: IP International Journal of Ocular Oncology and Oculoplasty - Year 2016, Vol 2, Issue 3

Abstract

Aim: The aim of this study is to analyse the treatment modalities for diabetic retinopathy and their efficacy in a rural setting. Materials and Methods: Patient selection: 50 patients who presented with diabetic retinopathy and who were treated for the same in the last 2 years were taken into consideration. All the patients were thoroughly evaluated which included careful history taking, vision assessment at the time presentation and after receiving treatment on 7th day, 1 month and 3 months, anterior segment examination, intro-ocular pressure measurement, posterior segment examination using indirect ophthalmoscopy and OCT analysis for quantitative assessment of macular edema. Results: We found that patients having diabetes for around 10 years had milder retinopathy changes while the patients having diabetes for more than 15 years had more severe retinopathy changes. There was significant reduction in visual acuity of patients with retinopathy changes compared to their age normal values. Improvement in vision was significantly more in patients treated with intravitreal bevacizumab. Conclusion: Diabetic retinopathy is a chronic progressive disorder. It takes several years to develop and further more years to manage. Due to the lack of awareness regarding the severity of this condition in a rural setting like ours the patients present at a very late stage. Early detection and early treatment is the crux of managing DR. It is therefore essential to educate the masses and motivate them for regular check-ups with an ophthalmologist once they are diagnosed with diabetes mellitus. It is important to counsel the patients that diabetic retinopathy cannot be cured in days or weeks. It takes months to years to control this condition. Besides the mainstay of the treatment is to prevent further damage. Patients are unaware about this and they expect a speedy visual recovery. This leads to dissatisfaction and hence patients fail to follow-up. Despite the fact that diabetic retinopathy is a curable condition we still face a lot of difficulties in managing it in a rural setting in developing countries.

Authors and Affiliations

Shrikant Deshpande, Prachi Shah, Yash Gala

Keywords

Related Articles

Clinical and histological profile of orbito-ocular masses in Ekiti

Purpose: To review the clinical and histological profile of patients with orbito-ocular masses in order to plan preventive strategies for ocular deformity and loss of life from these lesions. Methods: The clinic and thea...

Pleomorphic adenoma of the lacrimal gland in a teenager

Lacrimal gland pleomorphic adenoma, accounts for more than half of the epithelial forms of lacrimal gland tumours. The commonest age group affected is the fifth decade. We report this tumour in a teenaged girl which is a...

Ocular manifestations in cases of Bell’s Palsy

Introduction: Bell's Palsy accounts for around three-quarters of all cases of unilateral acute facial weakness which is diagnosed after excluding other causes of isolated facial weakness. They often cause ocular morbidit...

Multimodal strategic approach in the clinical assessment of malingering – keeping an eye on truth!!!

Purpose To evaluate patients who present with ophthalmic problems with no discernible organic cause and detect malingering in such casesMaterials and Methods 175 patients reporting to the Ophthalmology outpatient departm...

Autograft technique for pterygium surgery with no glue and no suture -cut and paste: Our experience

Background: Pterygium is a common disorder of the age and surgical excision with conjunctival autografting is the treatment of choice. But recurrence is the main problem. Use of sutures and glue to secure autograft is co...

Download PDF file
  • EP ID EP243713
  • DOI -
  • Views 104
  • Downloads 0

How To Cite

Shrikant Deshpande, Prachi Shah, Yash Gala (2016). Hindrances in management of diabetic retinopathy. IP International Journal of Ocular Oncology and Oculoplasty, 2(3), 199-202. https://europub.co.uk/articles/-A-243713